These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder. Soll AH; Fass R Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491 [TBL] [Abstract][Full Text] [Related]
6. A critical assessment of the current status of non-erosive reflux disease. Armstrong D Digestion; 2008; 78 Suppl 1():46-54. PubMed ID: 18832840 [TBL] [Abstract][Full Text] [Related]
7. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities. Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517 [TBL] [Abstract][Full Text] [Related]
8. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn. DeVault KR Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of patients with erosive and nonerosive GERD in high-Helicobacter-pylori prevalence region. Jonaitis LV; Kiudelis G; Kupcinskas L Dis Esophagus; 2004; 17(3):223-7. PubMed ID: 15361095 [TBL] [Abstract][Full Text] [Related]
10. Heartburn sensation in nonerosive reflux disease: pattern of superficial sensory nerves expressing TRPV1 and epithelial cells expressing ASIC3 receptors. Ustaoglu A; Sawada A; Lee C; Lei WY; Chen CL; Hackett R; Sifrim D; Peiris M; Woodland P Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G804-G815. PubMed ID: 33655767 [TBL] [Abstract][Full Text] [Related]
11. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Labenz J; Nocon M; Lind T; Leodolter A; Jaspersen D; Meyer-Sabellek W; Stolte M; Vieth M; Willich SN; Malfertheiner P Am J Gastroenterol; 2006 Nov; 101(11):2457-62. PubMed ID: 17029609 [TBL] [Abstract][Full Text] [Related]
12. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
13. Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease. Choi JY; Jung HK; Song EM; Shim KN; Jung SA Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):764-71. PubMed ID: 23459104 [TBL] [Abstract][Full Text] [Related]
14. Antireflux surgery is equally beneficial in nonerosive and erosive gastroesophageal reflux disease. Park JM; Chi KC Ann Surg Treat Res; 2018 Aug; 95(2):94-99. PubMed ID: 30079326 [TBL] [Abstract][Full Text] [Related]
15. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Wu JC; Cheung CM; Wong VW; Sung JJ Clin Gastroenterol Hepatol; 2007 Jun; 5(6):690-5. PubMed ID: 17481961 [TBL] [Abstract][Full Text] [Related]
16. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Neumann H; Monkemuller K; Kandulski A; Malfertheiner P Dig Dis; 2008; 26(3):243-7. PubMed ID: 18463443 [TBL] [Abstract][Full Text] [Related]
17. The natural history of gastro-esophageal reflux disease: a comprehensive review. Savarino E; de Bortoli N; De Cassan C; Della Coletta M; Bartolo O; Furnari M; Ottonello A; Marabotto E; Bodini G; Savarino V Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27862680 [TBL] [Abstract][Full Text] [Related]